Abstract

Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing death worldwide. The present study was conducted to investigate recent patterns of bladder cancer incidence and mortality worldwide. Patients and Methods: In the present study, information on the incidence and mortality of bladder cancer in different regions of the world was extracted from the International Agency for Research on Cancer (IARC) (GLOBOCAN, 2018). We provided the Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of bladder cancer per 100,000 population. Results: During 2018, 549,393 new cases of bladder cancer were diagnosed worldwide, 125,311 (22.80) of whom were female and 424,082 (77.19) were male. In general, the global ASIR of bladder cancer was 5.7 (2.4 in women and 9.6 in men). There were also 199,922 deaths from bladder cancer, 51,652 (25.83) of whom were female and 148,280 (74.16) were male. The global ASMR of bladder cancer was 1.9 (0.87 in women and 3.2 in men). Conclusions: The highest ASIR of bladder cancer was observed in North America, in regions with very high Human Development Index (HDI) and in Europe. The highest mortality due to bladder cancer was observed in Europe, in regions with very high human development index and in EMRO.